Most Liver Cancer Patients in China May Qualify for Tumor-Shrinking Therapy Before Surgery, Survey Finds
A nationwide survey of 120 senior Chinese specialists reveals that over half of newly diagnosed intermediate-stage liver cancer patients are ...
A nationwide survey of 120 senior Chinese specialists reveals that over half of newly diagnosed intermediate-stage liver cancer patients are ...
A new study shows that pachymic acid, a compound from the medicinal mushroom Poria cocos, synergizes with lenvatinib against hepatocellular ...
New research shows that triple therapy for unresectable liver cancer is associated with denser, more mature intratumoral tertiary lymphoid structures ...
A phase 1b/2 trial found that the oral CBP–β-catenin inhibitor E7386 combined with lenvatinib produced durable responses in advanced endometrial ...
In a groundbreaking advance that could redefine the therapeutic landscape for liver cancer, a new single-arm phase II clinical trial ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine